We have partnered with Enterin to grow the company from a newly founded, virtual company with limited resources to a venture-backed biotech having completed Series A + B financings, with a lead molecule in Phase 2b, and a growing international following and recognition as an innovator at the forefront of understanding the gut-brain axis and its role in neurodegenerative disease. We have provided Enterin with a suite of services across Strategy + Creative.
Our goal in supporting Enterin has been to showcase its unique and innovative focus on the gut-brain axis, the neurological connection between the gut and the brain. We have crafted a brand that draws attention and recongition. Our creative team has closely collaborated with Enterin to develop a logo, stationary, a responsive website and a series of multichannel materials for investors, physicians + patients, to reinforce that brand identity.
Among the various deliverables we have provided for Enterin, we have built the entire brand, identity and corporate website.
2016: Market Research | Analytics | Investor Relations | Identity | Branding 2017: Product Planning | Series A Valuation | Website | Corporate Presentation | Press Releases 2018: Product Planning | Series B Valuation | RASMET Study Materials | Social Media | Press Releases 2019: KARMET Study Materials | Social Media | Press Releases